findmyKOL
Clinical trialNCT06750484RecruitingPhase 2Interventional

Trial of Trastuzumab Deruxtecan in Previously Treated HER2

SponsorYale UniversityEnrollment40Breast Cancer Metastatic
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Yale University

    New Haven, Connecticut, United States

    Adriana Kahn, MD
    Recruiting
  • Emory Winship Cancer Institute

    Atlanta, Georgia, United States

    Elizabeth Sakach, MD
    Recruiting
  • University of Rochester Medical Center

    Rochester, New York, United States

    Ruth O'Regan, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Jun 2025
Primary completion
31 Dec 2028
Completion
31 Dec 2028
Last update posted
29 Jun 2026
Registered enrollment
40
Registry id
NCT06750484
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.